Shl Telemedicine (CH:SHLTN) has released an update.
SHL Telemedicine Ltd. reports a 3.1% revenue increase in the full year of 2023, reaching $57.1 million, despite a net loss of $6.9 million due to strategic investments and restructuring costs. The company highlights market strength with significant advancements in the US and German markets, including new virtual services and direct-to-consumer sales. Looking ahead, SHL expects continued revenue growth and profitability, particularly in its Israel operations and from its investment in the US and German markets.
For further insights into CH:SHLTN stock, check out TipRanks’ Stock Analysis page.